PUBLIC COMPANY
save$PBYIPUMA BIOTECHNOLOGY, INC.
$PBYILos Angeles, CA, USupdated 13d ago
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
community read0 votes
pipeline
2
marketed
1
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
1Phase 21Marketed
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
- phase2A Study of Alisertib and Paclitaxel in Patients With Small Cell Lung Cancer (SCLC)
- phase2A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
- phase2Basket Study of Neratinib in Participants With Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations
Insider activity
source: SEC Form 4routine RSU / option mechanics (6)
- Feb 18, 26grantAUERBACH ALAN H · President and CEO159,778 sh
- Feb 18, 26grantAUERBACH ALAN H · President and CEO227,474 sh
- Feb 18, 26grantHUNT DOUGLAS M · See Remarks49,394 sh
- Feb 18, 26grantHUNT DOUGLAS M · See Remarks70,321 sh
- Feb 18, 26grantNOUGUES MAXIMO F · Chief Financial Officer46,739 sh
- Feb 18, 26grantNOUGUES MAXIMO F · Chief Financial Officer66,541 sh
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 11m ago
Found something off?
comments(0)
5-min edit window · permanent after that